TY - JOUR
T1 - Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
AU - Golubchik, Pavel
AU - Sever, Jonathan
AU - Weizman, Abraham
PY - 2014/7
Y1 - 2014/7
N2 - The aim of this study was to assess the response of social phobia (SP) symptoms to methylphenidate (MPH) treatment in children with attention deficit hyperactivity disorder (ADHD). Twenty-one ADHD patients with SP, aged between 8 and 18 years, received 12 weeks of MPH treatment. The severity of SP symptoms were assessed by the Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA), and the severity of ADHD symptoms was assessed by the ADHD Rating Scale at baseline and at endpoint. MPH treatment was associated with a significant decrease in the ADHD Rating Scale scores (P<0.0001) and in the total LSAS-CA scores (P=0.013), as well as the school-related items of LSAS-CA (P=0.011). A significant correlation was found between the reductions in ADHD score and total LSAS-CA score (P=0.038), especially in school-related SP. The improvement in ADHD symptoms because of MPH treatment correlates with a parallel improvement in SP. MPH treatment appears to be safe and effective in ADHD/SP children.
AB - The aim of this study was to assess the response of social phobia (SP) symptoms to methylphenidate (MPH) treatment in children with attention deficit hyperactivity disorder (ADHD). Twenty-one ADHD patients with SP, aged between 8 and 18 years, received 12 weeks of MPH treatment. The severity of SP symptoms were assessed by the Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA), and the severity of ADHD symptoms was assessed by the ADHD Rating Scale at baseline and at endpoint. MPH treatment was associated with a significant decrease in the ADHD Rating Scale scores (P<0.0001) and in the total LSAS-CA scores (P=0.013), as well as the school-related items of LSAS-CA (P=0.011). A significant correlation was found between the reductions in ADHD score and total LSAS-CA score (P=0.038), especially in school-related SP. The improvement in ADHD symptoms because of MPH treatment correlates with a parallel improvement in SP. MPH treatment appears to be safe and effective in ADHD/SP children.
KW - attention deficit hyperactivity disorder
KW - children and adolescents
KW - methylphenidate
KW - social phobia
UR - http://www.scopus.com/inward/record.url?scp=84902157187&partnerID=8YFLogxK
U2 - 10.1097/YIC.0000000000000029
DO - 10.1097/YIC.0000000000000029
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84902157187
SN - 0268-1315
VL - 29
SP - 212
EP - 215
JO - International Clinical Psychopharmacology
JF - International Clinical Psychopharmacology
IS - 4
ER -